Financial PerformanceWELL Health Technologies Corp. reported 3Q24 results with revenue up 23% year-over-year, topping estimates and consensus.
Revenue GrowthManagement introduced 2025 revenue guidance of C$1.4B-C$1.45B, up 52%-58% y/y, and adjusted EBITDA of C$190M-C$210M, up 307%-350% y/y, both above estimates and consensus.
Strategic InitiativesExpanding primary clinics in Canada, new AI offerings, healthcare technologies, and potential spin-off of WELL's technology solutions all support a positive outlook.